Thermo Fisher to buy diagnostics firm Binding Site for $2.6 billion
[html](Reuters) -Thermo Fisher Scientific Inc said on Monday it would buy specialty diagnostics firm the Binding Site Group from a group led…
(Reuters) -Thermo Fisher Scientific Inc said on Monday it would buy specialty diagnostics firm the Binding Site Group from a group led by European private equity firm Nordic Capital in an all-cash transaction valued at 2.25 billion pounds ($2.6 billion).
The Birmingham-based co*pany’s test helps detect and monitor multiple myeloma, a cancer in a type of white blood cell, and is on track to deliver more than $220 million of revenue in 2022, Thermo Fisher said.
Thermo Fisher, which makes scientific instruments, expects the transaction to be co*pleted in the first half of 2023 and boost adjusted earnings per share by 7 cents on the first full-year of ownership.
(Reporting by Leroy Leo and Pratik Jain in Bengaluru; Editing by Sriraj Kalluvila)
[/html]
Source: Thermo Fisher to buy diagnostics firm Binding Site for $2.6 billion (http://ht**://www.oann.c**/business/thermo-fisher-to-buy/?utm_source=rss&utm_medium=rss&utm_campaign=thermo-fisher-to-buy)